Search Results

Extended Use Aldahol High Level Disinfectant is intended for the high level disinfection of reusable, clean, heat-sensitive, semi-critical medical devices which contact intact mucous membranes when the disinfectant is used at or above its minimum recommended concentration of 1.8% glutaraldehyde for 5.0 min at 25℃ in an automated endoscope reprocessor with FDA-cleared capability to maintain the exposure of 5.0 min at 25°C.

Extended Use Aldahol High Level Disinfectant is intended for the sterilization of reusable, clean, heat-sensitive critical and semi-critical medical devices which contact and potentially penetrate into sterile body areas, for which there is no other practical method of sterilization, when the disinfectant is used at or above its minimum recommended concentration of 1.8% glutaraldehyde for 6.0 hrs at 25℃.

Extended Use Aldahol High Level Disinfectant (HLD) is an aqueous solution that requires the combination of two parts, the unactivated Extended Use Aldahol HLD solution, packaged in gallon-sized containers, and a red Activator Buffer Salt Solution packaged in a smaller container included with the unactivated Extended Use Aldahol HLD solution container.

Once activated, the red/red-orange Extended Use Aldahol HLD as manufactured contains 3.4% w/w of glutaraldehyde and 20.1% w/w of isopropanol in a buffered salt solution of a surfactant, and potassium acetate intended to enhance the antimicrobial activity of the glutaraldehyde.

The microbial mode of action of glutaraldehyde has been extensively studied and reviewed since glutaraldehyde was introduced as a disinfectant in the late 1960's. All of these reviews indicate that glutaraldehyde cross-links proteins and lipoproteins of microbes to denature the proteins and lipoproteins, thus killing the cells.

The provided text describes the safety and effectiveness testing for the Extended Use Aldahol High Level Disinfectant. While it outlines the efficacy of the disinfectant against various microorganisms and its performance in simulated-use and clinical-use studies, it does not provide information on an AI-powered device or an algorithm. The document is a 510(k) summary for a liquid chemical disinfectant, which is a chemical product, not a medical device in the context of an "algorithm" or "AI assistance" as implied by the request's structure.

Therefore, the requested information pertaining to acceptance criteria of an AI device, sample sizes for test/training sets, expert consensus, MRMC studies, or standalone algorithm performance, cannot be extracted from this document.

The document details the performance of the disinfectant based on meeting regulatory standards for various antimicrobial activities, material compatibility, and stability.

Here's a breakdown of what can be extracted, framed to the best of my ability given the constraint of the request:

1. Table of Acceptance Criteria and Reported Device Performance (as a disinfectant):

Since the request is about an AI device and the document describes a chemical disinfectant, the following points are not applicable and cannot be answered:

2. Sample sizes used for the test set and the data provenance (e.g. country of origin of the data, retrospective or prospective) - This applies to imaging/diagnostic devices, not chemical disinfectants. The "sample" for this device refers to microorganisms and medical devices, not patient data.
3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts (e.g., radiologist with 10 years of experience) - Not applicable to a chemical disinfectant.
4. Adjudication method (e.g. 2+1, 3+1, none) for the test set - Not applicable.
5. If a multi-reader multi-case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance - Not applicable as this is not an AI device.
6. If a standalone (i.e. algorithm only, without human-in-the-loop performance) was done - Not applicable.
7. The type of ground truth used (expert consensus, pathology, outcomes data, etc.) - For antimicrobial tests, the "ground truth" is typically the absence or presence and quantity of viable microorganisms after exposure, determined by standard microbiological culturing and counting methods, not expert consensus or pathology in the AI sense.
8. The sample size for the training set - Not applicable as there is no AI algorithm being trained.
9. How the ground truth for the training set was established - Not applicable.

Ask a specific question about this device

Sterilization: Aldahol III High-Level Disinfectant is a sterilant intended for the sterilization of reusable, clean, heat-sensitive medical devices when used as directed at or above its minimum recommended concentrations (MRC) of 2.1% alkaline glutaraldehyde and 15.0% isopropanol with an exposure of 10.0 hrs at 20 C.

High-Level Disinfection: Aldahol III High-Level Disinfectant is a high-level disinfectant intended for the disinfection of reusable, clean, heat-sensitive medical devices when used as directed at or above its MRC of 2.1% alkaline glutaraldehyde and 15.0% isopropanol with an exposure of 10.0 min at 20 C.

Aldahol III High-Level Disinfectant is a liquid chemical sterilant and high-level disinfectant. It is a glutaraldehyde-based disinfectant with a glutaraldehyde concentration in the range of 2.4 to 3.4%. When activated with buffer salts to an alkaline pH value of about 7.6, the glutaraldehyde concentration can remain constant over a 14-day use and reuse life. It also contains about 25% isopropanol to enhance mycobactericidal (TB) activity.

The provided text describes a liquid chemical sterilant and high-level disinfectant called "Aldahol III High-Level Disinfectant" and its substantial equivalence to the predicate device "Cidex Activated Dialdehyde Solution." The document focuses on the efficacy testing of Aldahol III.

Here's an analysis of the acceptance criteria and the studies that prove the device meets these criteria, based on the provided text:

1. Table of Acceptance Criteria and Reported Device Performance

The text doesn't explicitly state "acceptance criteria" as a set of quantified thresholds in a table format. Instead, it describes various tests performed and the positive results achieved. The implicit acceptance criterion for each test is the complete elimination or reduction of the target microorganisms to undetectable levels within specified exposure times and conditions.

Notes on reported performance:

• All tests for Aldahol III HLD were conducted at a "worst case" glutaraldehyde concentration of 2.0% (from a 14-day EPA Re-Use Test), which is below its initial concentration of 3.4%.
• The high-level disinfection goal exposure time is 10.0 minutes at 20°C.
• The sterilization goal exposure time is 10.0 hours at 20°C.

2. Sample Size Used for the Test Set and Data Provenance

The text describes experimental setups rather than typical clinical trial sample sizes.

• Bacterial Use Dilution Tests (i-1): Stainless steel "penicylinders" were labeled with cultures. The number of cylinders per test is not explicitly stated, but standard AOAC methods typically involve multiple replicates (e.g., 10-60 carriers per organism per disinfectant dilution). The data provenance is laboratory-based efficacy testing.
• Fungicidal Tests (i-2): Cultures of Trichophyton mentagrophytes, Aspergillus niger, or Candida albicans were tested. Methodology similar to bacterial tests. Data provenance is laboratory-based efficacy testing.
• Virucidal Tests (i-3): Poliovirus type 1, Influenza A Virus, Herpes Simplex Virus type 1, and Adenovirus type 2 were tested. Data provenance is laboratory-based efficacy testing.
• Mycobactericidal Tests (i-4): M. terrae (6 log10 challenge). Data provenance is laboratory-based efficacy testing.
• Sterilization Exposure Studies (i-5, i-6, i-7):
  • Initial study (i-5) tested 40 spore-labeled carriers for C. sporogenes (4 positive at 4.0 hrs, all others disinfected). This indicates a sample size of 40 carriers per exposure time for initial optimization.
  • Full three Lot test (i-6) passed the AOAC Sporicidal Test with an exposure of 10.0 hours. Standard AOAC Sporicidal Test (966.04) involves multiple spore carriers (often around 60 per condition/lot).
  • Confirmatory Sporicidal Test (i-7) also passed. Implies similar sample sizes to the full Lot test.
  • Data provenance is laboratory-based efficacy testing.
• Simulated Use Tests with Flexible Endoscopes (i-8): Flexible endoscopes' biopsy channels were labeled with M. terrae. The number of endoscopes is not specified but usually involves a representative number for such tests (e.g., 3-10). Data provenance is simulated-use laboratory testing.
• Clinical In-use Tests (i): "Various colonoscopes and gastroscopes" as received directly from patients at an endoscopy clinic. The exact number is not stated but implies real-world clinical samples. Data provenance is prospective clinical in-use testing, likely U.S. based given the FDA submission.

3. Number of Experts and Qualifications for Ground Truth

This type of submission is for a disinfectant, not for an image-based diagnostic or AI algorithm. Therefore, the concept of "experts establishing ground truth" in the medical imaging sense (e.g., radiologists, pathologists) is not directly applicable.

Instead, the "ground truth" is established by:

• Standardized microbiological methods: Adherence to AOAC (Association of Official Analytical Chemists) protocols (e.g., 955.14, 955.15, 964.02 for bacteria; 955.17 for fungi; 966.04 for sporicidal) for determining the presence or absence of viable microorganisms.
• Laboratory Technicians/Scientists: These individuals, qualified in microbiology and sterilization/disinfection testing, perform the tests and interpret the results according to the established protocols. Their qualification is implied by their ability to successfully execute these validated methods.
• Clinical Personnel: For the clinical in-use tests, clinic personnel followed standard cleaning procedures and microbiologists determined the presence/absence of bacteria.

4. Adjudication Method for the Test Set

Adjudication methods like 2+1 or 3+1 consensus are typically used for subjective assessments in clinical trials or image interpretation. For microbiological efficacy testing, the outcome is generally objective: growth or no growth, colony count reduction, or presence/absence of detectable virus. The "adjudication" is inherent in the rigorous, standardized nature of the AOAC methods and the clear criteria for positive/negative results. Any discrepancies would likely trigger re-testing or investigation, but not a consensus process among human readers.

5. Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study

No. This is not applicable to a liquid chemical sterilant/disinfectant. MRMC studies are used for evaluating the reader performance of diagnostic tools, particularly in medical imaging, and assessing the impact of AI assistance on human readers.

6. Standalone Performance

Yes, the studies described are all "standalone" in the sense that they evaluate the efficacy of the Aldahol III High-Level Disinfectant itself, without human intervention in the disinfection process beyond proper application. The results (e.g., 100% kill, 6 log10 reduction) directly reflect the algorithm's (the chemical formulation's) performance.

7. Type of Ground Truth Used

The ground truth used is primarily microbiological culture results and virological assays (for virucidal tests). This involves:

• Direct observation of microbial growth/no growth: After exposure to the disinfectant, samples are cultured to see if any viable organisms remain.
• Quantitative reduction: For some tests (e.g., mycobactericidal), the ground truth involves measuring the reduction in the number of colony-forming units (CFUs) or viral particles.
• Absence of detectable organisms: The ultimate ground truth for disinfection and sterilization is the absence of the target microorganisms.

8. Sample Size for the Training Set

The concept of a "training set" is not applicable here as this is a chemical disinfectant, not a machine learning model. The formulation of Aldahol III HLD (3.4% glutaraldehyde, 25% isopropanol) and its activation (alkaline pH) are based on chemical and microbiological principles developed over time through research and previous product development, not through training a model on a dataset.

9. How the Ground Truth for the Training Set was Established

Again, the concept of a "training set" in the context of AI development does not apply. The "ground truth" for the development of glutaraldehyde-based disinfectants and the concept of enhanced mycobactericidal activity with alcohol are established through decades of traditional chemical and microbiological research, understanding of antiseptic mechanisms, and empirical testing. This would involve laboratory experiments, dose-response curves, kinetics studies, and comparisons with known effective agents, not a "training set" with established ground truth.

Ask a specific question about this device